Tech Company Financing Transactions
Grail Funding Round
Braidwell, Deep Track Capital and Farallon Capital Management participated in a $325 million capital raise for Grail. The round was announced by the company on 10/20/2025.
Transaction Overview
Company Name
Announced On
10/20/2025
Transaction Type
Venture Equity
Amount
$325,000,000
Round
Undisclosed
Proceeds Purpose
GRAIL currently expects to use the net proceeds from the private placement to fund its commercial activities and reimbursement efforts, as well as for working capital and other general corporate purposes.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1525 O'Brien Dr.
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Grail's mission is to detect cancer early, when it can be cured.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hans Bishop
Chief Medical Officer
Joshua Ofman
Chief Operating Officer
Matthew Young
President
Harpal Kumar
VP - Bus. Development
Gautam Kollu
VP - General Counsel
Marissa Song
VP - R & D
Alex Aravanis
Browse more venture capital transactions:
Prev: 10/20/2025: Magma Math venture capital transaction
Next: 10/20/2025: Alto Neuroscience venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions on this site are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs